Overexpression of Smad2 drives house dust mite-mediated airway remodeling and airway hyperresponsiveness via activin and IL-25.

RATIONALE Airway hyperreactivity and remodeling are characteristic features of asthma. Interactions between the airway epithelium and environmental allergens are believed to be important in driving development of pathology, particularly because altered epithelial gene expression is common in individuals with asthma. OBJECTIVES To investigate the interactions between a modified airway epithelium and a common aeroallergen in vivo. METHODS We used an adenoviral vector to generate mice overexpressing the transforming growth factor-beta signaling molecule, Smad2, in the airway epithelium and exposed them to house dust mite (HDM) extract intranasally. MEASUREMENTS AND MAIN RESULTS Smad2 overexpression resulted in enhanced airway hyperreactivity after allergen challenge concomitant with changes in airway remodeling. Subepithelial collagen deposition was increased and smooth muscle hyperplasia was evident resulting in thickening of the airway smooth muscle layer. However, there was no increase in airway inflammation in mice given the Smad2 vector compared with the control vector. Enhanced airway hyperreactivity and remodeling did not correlate with elevated levels of Th2 cytokines, such as IL-13 or IL-4. However, mice overexpressing Smad2 in the airway epithelium showed significantly enhanced levels of IL-25 and activin A after HDM exposure. Blocking activin A with a neutralizing antibody prevented the increase in lung IL-25 and inhibited subsequent collagen deposition and also the enhanced airway hyperreactivity observed in the Smad2 overexpressing HDM-exposed mice. CONCLUSIONS Epithelial overexpression of Smad2 can specifically alter airway hyperreactivity and remodeling in response to an aeroallergen. Moreover, we have identified novel roles for IL-25 and activin A in driving airway hyperreactivity and remodeling.

[1]  D. Curran‐Everett,et al.  Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. , 2010, American journal of respiratory and critical care medicine.

[2]  P. Howarth,et al.  The role of the airway epithelium and its interaction with environmental factors in asthma pathogenesis. , 2009, Proceedings of the American Thoracic Society.

[3]  Christopher P. Thomas,et al.  Inhaled house dust mite induces pulmonary T helper 2 cytokine production , 2009, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[4]  D. Robinson,et al.  Activin-A induces regulatory T cells that suppress T helper cell immune responses and protect from allergic airway disease , 2009, The Journal of experimental medicine.

[5]  M. Jordana,et al.  TGF-beta, eosinophils and IL-13 in allergic airway remodeling: a critical appraisal with therapeutic considerations. , 2008, Inflammation & allergy drug targets.

[6]  K. Chung,et al.  Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma. , 2007, The Journal of allergy and clinical immunology.

[7]  P. Sime,et al.  TGF-β, Smad3 and the process of progressive fibrosis , 2007 .

[8]  Yong‐jun Liu,et al.  Interleukin 25 promotes the initiation of proallergic type 2 responses , 2007, The Journal of experimental medicine.

[9]  R. Murphy,et al.  The regulatory role of TGF‐β in airway remodeling in asthma , 2007 .

[10]  P. Foster,et al.  Mechanism of interleukin‐25 (IL‐17E)‐induced pulmonary inflammation and airways hyper‐reactivity , 2006, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[11]  Kotaro Suzuki,et al.  IL-25 enhances allergic airway inflammation by amplifying a TH2 cell-dependent pathway in mice. , 2006, The Journal of allergy and clinical immunology.

[12]  Q. Hamid,et al.  TNF-α and IFN-γ inversely modulate expression of the IL-17E receptor in airway smooth muscle cells , 2006 .

[13]  C. Akdis,et al.  T-cell subsets in the pathogenesis of human asthma , 2006, Current allergy and asthma reports.

[14]  Sarah J. McMillan,et al.  Manipulation of Allergen-Induced Airway Remodeling by Treatment with Anti-TGF-β Antibody: Effect on the Smad Signaling Pathway1 , 2005, The Journal of Immunology.

[15]  C. Heldin,et al.  TGF-beta and the Smad signaling pathway support transcriptomic reprogramming during epithelial-mesenchymal cell transition. , 2005, Molecular biology of the cell.

[16]  C. Schmidt‐Weber,et al.  Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. , 2004, Current opinion in immunology.

[17]  M. Wills-Karp,et al.  Interleukin‐13 in asthma pathogenesis , 2004, Immunological reviews.

[18]  M. Inman,et al.  Is interleukin-13 critical in maintaining airway hyperresponsiveness in allergen-challenged mice? , 2004, American journal of respiratory and critical care medicine.

[19]  R. Derynck,et al.  JNK Regulates Expression and Autocrine Signaling of TGF-β1 , 2004 .

[20]  H. Kuwano,et al.  The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. , 2004, Endocrinology.

[21]  Marsha Wills Karp.  Interleukin-13 in asthma pathogenesis , 2004 .

[22]  S. Holgate,et al.  The airway epithelium: Structural and functional properties in health and disease , 2003, Respirology.

[23]  S. Holgate,et al.  Airway remodeling in asthma: new insights. , 2003, The Journal of allergy and clinical immunology.

[24]  D. Knight.  Increased permeability of asthmatic epithelial cells to pollutants. Does this mean that they are intrinsically abnormal? , 2002, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[25]  T. Fukuda,et al.  Activation of TGF-beta/Smad2 signaling is associated with airway remodeling in asthma. , 2002, The Journal of allergy and clinical immunology.

[26]  C. Heldin,et al.  Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. , 2001, American journal of respiratory cell and molecular biology.

[27]  D. Anthony,et al.  Transient expression of IL-1beta induces acute lung injury and chronic repair leading to pulmonary fibrosis. , 2001, The Journal of clinical investigation.

[28]  J. Bousquet,et al.  Is allergic asthma associated with delayed fetal maturation or the persistence of conserved fetal genes? , 2000, Allergy.

[29]  D. J. Matthews,et al.  IL-9-deficient mice establish fundamental roles for IL-9 in pulmonary mastocytosis and goblet cell hyperplasia but not T cell development. , 2000, Immunity.

[30]  Anita B. Roberts,et al.  Mice lacking Smad3 show accelerated wound healing and an impaired local inflammatory response , 1999, Nature Cell Biology.

[31]  S. Werner,et al.  A novel role of activin in inflammation and repair. , 1999, The Journal of endocrinology.

[32]  R. Homer,et al.  Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. , 1999, The Journal of clinical investigation.

[33]  R. Locksley,et al.  Requirement for IL-13 independently of IL-4 in experimental asthma. , 1998, Science.

[34]  R. E. Wiley,et al.  GM-CSF transgene expression in the airway allows aerosolized ovalbumin to induce allergic sensitization in mice. , 1998, The Journal of clinical investigation.

[35]  H. Asakura,et al.  Expression of activin A is increased in cirrhotic and fibrotic rat livers. , 1998, Gastroenterology.

[36]  E. Gelfand,et al.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography. , 1997, American journal of respiratory and critical care medicine.

[37]  K. Csaky,et al.  Adenovector-mediated gene transfer of active transforming growth factor-beta1 induces prolonged severe fibrosis in rat lung. , 1997, The Journal of clinical investigation.

[38]  Farhad Imani,et al.  A genome-wide search for asthma susceptibility loci in ethnically diverse populations , 1997, Nature Genetics.

[39]  Y. Ouchi,et al.  Expression of immunoreactive activin A protein in remodeling lesions associated with interstitial pulmonary fibrosis. , 1996, The American journal of pathology.

[40]  S. Werner,et al.  Strong induction of activin expression after injury suggests an important role of activin in wound repair. , 1996, Developmental biology.

[41]  Y. Kasuya,et al.  Activin A stimulates mitogenesis in Swiss 3T3 fibroblasts without activation of mitogen-activated protein kinases. , 1994, The Journal of biological chemistry.

[42]  H. Mogami,et al.  Modulation of growth of vascular smooth muscle cells by activin A. , 1993, Experimental cell research.

[43]  M. Sporn,et al.  Autoinduction of transforming growth factor beta 1 is mediated by the AP-1 complex , 1990, Molecular and cellular biology.

[44]  J. Drazen,et al.  Pulmonary responses to bronchoconstrictor agonists in the mouse. , 1988, Journal of applied physiology.

[45]  M. Jordana,et al.  Transforming growth factor-beta regulates house dust mite-induced allergic airway inflammation but not airway remodeling. , 2008, American journal of respiratory and critical care medicine.

[46]  S. Holgate.  The airway epithelium is central to the pathogenesis of asthma. , 2008, Allergology international : official journal of the Japanese Society of Allergology.

[47]  G. Menz,et al.  Activin A is an acute allergen-responsive cytokine and provides a link to TGF-beta-mediated airway remodeling in asthma. , 2006, The Journal of allergy and clinical immunology.

[48]  A. B. Kay,et al.  The role of T lymphocytes in asthma. , 2006, Chemical immunology and allergy.

[49]  Susan J Wilson,et al.  Epithelial-mesenchymal communication in the pathogenesis of chronic asthma. , 2004, Proceedings of the American Thoracic Society.